Accelerate Diagnostics, Inc.
Extract: Bylaws Amended/Restated (Plain English Desc) from a 8-K on 08/08/2019   Download
SEC Document
SEC Filing

On August 2, 2019, the Board amended and restated the Company’s bylaws (the “Amended and Restated Bylaws”) to, among other things:


·incorporate an advance notice provisions relating to certain timing and information requirements for stockholder nominations and proposals brought before a meeting of the stockholders by a stockholder of record;


·clarify director nominee eligibility requirements and procedures for nomination;


·add a Delaware forum selection provision for adjudication of certain disputes;


·update the indemnification provisions to conform to the indemnification provisions in the Company’s charter; and


·make certain other technical, procedural, conforming and clarifying changes in order to, among other things, reflect current market practices.